Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
UC Irvine's OctoPath Lab seeks exceptional postdoctoral research fellows to develop deep learning and computational methods for pathology image analysis, multimodal data integration, and emerging medical modalities.
Ideal candidates hold a PhD, have a strong publication record, and are experienced in ML/DL, Python, and PyTorch; appointments are for two years with renewal based on performance.
Salary range: $66,737–$80,034. The posted UC salary scales set the minimum pay determined by experience level. See: Postdoc Scholar Salary Scale.
Effective 10/1/26: The salary range is $71,491–$85,736. See: Postdoc Scholar Salary Scale.
Open date: July 1, 2026.
Next review date: Saturday, Aug 1, 2026 at 11:59pm (Pacific Time). Apply by this date to ensure full consideration by the committee.
Final date: Wednesday, Jun 30, 2027 at 11:59pm (Pacific Time). Applications will continue to be accepted until this date, but those received after the review date will only be considered if the position has not yet been filled.
The OctoPath Lab led by Prof. Lipkova is seeking applications from exceptional postdoctoral research fellows interested in developing deep learning and computational methods for pathology image analysis, multimodal data integration, and other medical modalities (e.g., proteomics, spatial transcriptomics, genomics, radiology). Postdoctoral applicants should have a PhD, a solid publication record, and strong professional references. The ideal candidate should have a significant mathematical and computational background to learn and develop new AI methods. While demonstrated experience in computer vision and deep learning for pathology or other biomedical image analysis is desirable, applicants with a strong machine learning background and an interest in transitioning to biomedical data science are also encouraged to apply. Initial appointments are for two years and renewal is based on performance and available support.
The lab focuses on developing AI methods to improve patient diagnosis, prognosis, treatment response prediction, and treatment optimization. We are particularly interested in:
1) developing novel AI methods for analyzing pathology data,
2) multimodal data fusion strategies,
3) development of computational methods for rare diseases and new modalities (e.g., multiphoton microscopy), and
4) translating AI solutions into clinical practice through the development of AI-based embedded devices.
We are committed to applying these techniques to pressing clinical needs in medicine, including oncology, immunology, organ transplantation, and neurodegenerative diseases, while making our tools accessible to the research and medical communities. Our lab is part of the UCI School of Medicine which includes the Chao Family Comprehensive Cancer Center, one of the top National Cancer Institutes in USA, and we are affiliated with the UCI School of Biomedical Engineering. As part of UCI Health, we work with UCI’s main teaching hospital, the Douglas Hospital, as well as many of UCI’s recently acquired community hospitals. In addition, the lab benefits from proximity to healthcare startups, biotechnology firms, and a thriving biomedical community, allowing for networking and translational research opportunities. The lab has further strong collaboration with universities and medical centers across USA and Europe, offering exciting opportunities and a vibrant research environment.
Inquiries & questions should be directed to Prof. Jana Lipkova (jlipkova@hs.uci.edu).
http://www.octopath.org
https://recruit.ap.uci.edu/JPF10254
The University of California, Irvine is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC anti-discrimination policy.
As a condition of employment, the finalist will be required to disclose if they are subject to any final administrative or judicial decisions within the last seven years determining that they committed any misconduct.